A 36-year-old woman with a 2-week history of fever and markedly elevated lactate dehydrogenase levels. Nonenhanced CT and contrast-enhanced CT showed hepatosplenomegaly, diffusely decreased attenuation of the liver, and homogeneous enhancement in the hepatic and splenic parenchyma. F-FDG PET/CT revealed diffuse intense heterogeneous uptake by the liver (like superscan in bone scintigraphy). A liver needle biopsy confirmed the diagnosis of hepatosplenic alphabeta T-cell lymphoma. Subsequently, she received chemotherapy. The follow-up F-FDG PET/CT showed decreased F-FDG uptake in the liver and spleen.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0000000000002134 | DOI Listing |
Ann Hematol
December 2024
Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Sipulan Road, Yanjiao Development Area, Hebei, Langfang, 065201, China.
Front Cell Dev Biol
August 2024
Laboratory of Molecular Hematology, National Medical Research Center for Hematology, Moscow, Russia.
Biomedicines
April 2024
Laboratory of Clinical Research and Advanced Diagnostics, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero In Vulture, Italy.
J Hematol
April 2024
Department of Pathology, HCA East Florida, Fort Lauderdale, FL, USA.
Hepatosplenic T-cell lymphoma (HSTCL) is rare and clinically very aggressive T-cell lymphoma. The majority of cases harbor γδ T-cell receptors (TCRs); however, in some even rarer cases, tumor cells harbor αβ TCR. Recent studies suggest that αβ cases may have distinct morphological characteristics and demonstrate an even more aggressive course.
View Article and Find Full Text PDFTransplant Cell Ther
April 2024
Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russia. Electronic address:
Mature T/NK-cell lymphomas (MTCLs) are a heterogeneous group of lymphoproliferative disorders, relatively rare in adults and children. Allogeneic hematopoietic stem cell transplantation (HSCT) can be considered in some cases as a consolidation and is the first choice for refractory forms and relapses. We retrospectively analyzed 19 pediatric patients with MTCL who received allogeneic hematopoietic stem cell transplantation from a haploidentical or unrelated donor on the αβ T cell depletion platform.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!